...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Promissory Notes

The latest posted interim financials for ZCC on SEDAR is dated March 28, 2023.

For the six-month period ending Jan 31, 2023.

 

Koo

Share
New Message
Please login to post a reply